Orthofix Medical (OFIX) Profit After Tax (2010 - 2026)

Orthofix Medical has disclosed Profit After Tax across 17 years of filings, most recently posting -$20.9 million for Q1 2026.

• Quarterly Profit After Tax rose 60.62% year-over-year to -$20.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$60.0 million (up 58.06% YoY) and the FY2025 annual result came in at -$92.2 million, up 26.83% from the prior year.
• Profit After Tax retreated to -$20.9 million in Q1 2026, from -$2.2 million in the prior quarter.
• Over five years, Profit After Tax peaked at $2.5 million in Q2 2022 and troughed at -$60.9 million in Q1 2023.
• A 5-year average of -$24.1 million and a median of -$22.8 million in 2025 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2023 — Profit After Tax sank 1684.01% — and 2025, when it jumped 92.38%.
• Tracing OFIX's Profit After Tax over 5 years: stood at -$7.1 million in 2022, then sank by 213.99% to -$22.2 million in 2023, then tumbled by 31.44% to -$29.1 million in 2024, then soared by 92.38% to -$2.2 million in 2025, then tumbled by 840.95% to -$20.9 million in 2026.
• Business Quant data shows OFIX's Profit After Tax at -$20.9 million in Q1 2026, -$2.2 million in Q4 2025, and -$22.8 million in Q3 2025.